Growth Metrics

Merck (MRK) Current Assets (2016 - 2026)

Merck has reported Current Assets over the past 18 years, most recently at $35.0 billion for Q1 2026.

  • Quarterly Current Assets fell 1.37% to $35.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35.0 billion through Mar 2026, down 1.37% year-over-year, with the annual reading at $43.5 billion for FY2025, 12.21% up from the prior year.
  • Current Assets was $35.0 billion for Q1 2026 at Merck, down from $43.5 billion in the prior quarter.
  • Over five years, Current Assets peaked at $47.6 billion in Q3 2025 and troughed at $30.0 billion in Q2 2023.
  • The 5-year median for Current Assets is $35.0 billion (2026), against an average of $35.7 billion.
  • Year-over-year, Current Assets fell 9.95% in 2023 and then grew 27.45% in 2024.
  • A 5-year view of Current Assets shows it stood at $35.7 billion in 2022, then fell by 9.95% to $32.2 billion in 2023, then increased by 20.56% to $38.8 billion in 2024, then rose by 12.21% to $43.5 billion in 2025, then dropped by 19.54% to $35.0 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Current Assets are $35.0 billion (Q1 2026), $43.5 billion (Q4 2025), and $47.6 billion (Q3 2025).